Showing 708 results
-
Media Release /
-
Media Release /- Exforge HCT combines a proven calcium channel blocker, angiotensin receptor blocker and diuretic (amlodipine, valsartan, hydrochlorothiazide) in one pill - In a clinical trial, Exforge HCT…
-
Media Release /
-
Media Release /Use of Gleevec after surgery shows significant benefit for gastrointestinal stromal tumor (GIST) patients, dramatically reducing risk of relapse GIST, a life-threatening cancer, recurs in as many…
-
Media Release /
-
Media Release /- RAD001 combined with Herceptin and chemotherapy in two separate Phase I trials halted tumor growth in 77% and 62% of patients, respectively- Novartis to start Phase III clinical trial program to…
-
Media Release /
-
Media Release /- Partnership aims to provide convenient access to vaccination - helping keep kids and teachers in school and parents at work- "Let's Fight Flu Together!" initiative supports CDC's new vaccination…
-
Media Release /
-
Media Release /-- Exploratory study shows clinical improvement in patients with pulmonary arterial hypertension (PAH) -- Current treatment options have limited benefit for this debilitating, rapidly progressive and…
